4//SEC Filing
Huang Alan 4
Accession 0000899243-23-006728
CIK 0001819133other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:05 PM ET
Size
7.6 KB
Accession
0000899243-23-006728
Insider Transaction Report
Form 4
Huang Alan
Chief Scientific Officer
Transactions
- Award
Common Stock
2023-03-01+31,697→ 167,584 total - Award
Stock Option (Right to Buy)
2023-03-01+190,181→ 190,181 totalExercise: $5.20Exp: 2033-03-01→ Common Stock (190,181 underlying)
Footnotes (2)
- [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 1/3 on February 5, 2024, 1/3 on February 3, 2025 and 1/3 on February 2, 2026 subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- [F2]This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Tango Therapeutics, Inc.
CIK 0001819133
Entity typeother
Related Parties
1- filerCIK 0001877364
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:05 PM ET
- Size
- 7.6 KB